Rekvina Laboratories Board Meeting on August 13, 2026

The Board Meeting is scheduled to be held on 13th August, 2026. The agenda items include:

• Consideration and approval of Un-Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter ended on 30th June, 2026
• Any other agendas as may be considered necessary with the permission of the chair

In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has implemented a trading window closure for its 'designated persons'. The trading window for trading in the Company's equity shares has been closed from 1st July, 2026 and will remain closed until the expiry of 48 hours from the date the said financial results are made public.

The disclosure is signed by Surbhit Shah (Director, DIN: 01993300) on behalf of Rekvina Laboratories Limited (CIN: L24231GJ1988PLC01145).